Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Censoring Survival Data01:09

Censoring Survival Data

Survival analysis is a statistical method used to analyze time-to-event data, often employed in fields such as medicine, engineering, and social sciences. One of the key challenges in survival analysis is dealing with incomplete data, a phenomenon known as "censoring." Censoring occurs when the event of interest (such as death, relapse, or system failure) has not occurred for some individuals by the end of the study period or is otherwise unobservable, and it might have many different reasons...
Assumptions of Survival Analysis01:15

Assumptions of Survival Analysis

Survival models analyze the time until one or more events occur, such as death in biological organisms or failure in mechanical systems. These models are widely used across fields like medicine, biology, engineering, and public health to study time-to-event phenomena. To ensure accurate results, survival analysis relies on key assumptions and careful study design.
Comparing the Survival Analysis of Two or More Groups01:20

Comparing the Survival Analysis of Two or More Groups

Survival analysis is a cornerstone of medical research, used to evaluate the time until an event of interest occurs, such as death, disease recurrence, or recovery. Unlike standard statistical methods, survival analysis is particularly adept at handling censored data—instances where the event has not occurred for some participants by the end of the study or remains unobserved. To address these unique challenges, specialized techniques like the Kaplan-Meier estimator, log-rank test, and Cox...
Kaplan-Meier Approach01:24

Kaplan-Meier Approach

The Kaplan-Meier estimator is a non-parametric method used to estimate the survival function from time-to-event data. In medical research, it is frequently employed to measure the proportion of patients surviving for a certain period after treatment. This estimator is fundamental in analyzing time-to-event data, making it indispensable in clinical trials, epidemiological studies, and reliability engineering. By estimating survival probabilities, researchers can evaluate treatment effectiveness,...
Statistical Methods for Analyzing Epidemiological Data01:25

Statistical Methods for Analyzing Epidemiological Data

Epidemiological data primarily involves information on specific populations' occurrence, distribution, and determinants of health and diseases. This data is crucial for understanding disease patterns and impacts, aiding public health decision-making and disease prevention strategies. The analysis of epidemiological data employs various statistical methods to interpret health-related data effectively. Here are some commonly used methods:
Parametric Survival Analysis: Weibull and Exponential Methods01:14

Parametric Survival Analysis: Weibull and Exponential Methods

Parametric survival analysis models survival data by assuming a specific probability distribution for the time until an event occurs. The Weibull and exponential distributions are two of the most commonly used methods in this context, due to their versatility and relatively straightforward application.
Weibull Distribution
The Weibull distribution is a flexible model used in parametric survival analysis. It can handle both increasing and decreasing hazard rates, depending on its shape parameter...

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Robust median regression for count data with general lower truncation using a contaminated discrete Weibull model.

The international journal of biostatistics·2026
Same author

Simlukafusp alfa (FAP-IL2v) plus atezolizumab with or without bevacizumab in unresectable, metastatic renal cell carcinoma: a randomized, open-label phase Ib study.

Journal for immunotherapy of cancer·2026
Same author

Addressing outliers in mixed-effects logistic regression: a more robust modeling approach.

Journal of applied statistics·2026
Same author

Phase I Study of Mosperafenib, a Novel Paradox Breaker B-Raf Proto-Oncogene Serine/Threonine Kinase (BRAF) Inhibitor, in Patients With <i>BRAF</i> V600-Mutant Solid Tumors.

Journal of clinical oncology : official journal of the American Society of Clinical Oncology·2026
Same author

Focused information criteria for model selection - a Bayesian perspective.

Journal of applied statistics·2026
Same author

Biomarkers of activity from a phase I study of cergutuzumab amunaleukin in patients with advanced solid tumors.

Journal for immunotherapy of cancer·2026
Same journal

A Bayesian functional concurrent zero-inflated Dirichlet-multinomial regression model with application to infant microbiome.

Biostatistics (Oxford, England)·2026
Same journal

Towards optimal environmental policies: policy learning under arbitrary bipartite network interference.

Biostatistics (Oxford, England)·2026
Same journal

Multilevel functional quantile principal component analysis.

Biostatistics (Oxford, England)·2026
Same journal

Adaptive transfer learning for time-to-event modeling with applications in disease risk assessment.

Biostatistics (Oxford, England)·2026
Same journal

High-dimensional test for one-sided hypotheses.

Biostatistics (Oxford, England)·2026
Same journal

NBSR: a Negative Binomial Softmax Regression model for microRNA-seq data analysis.

Biostatistics (Oxford, England)·2026
See all related articles

Related Experiment Video

Updated: May 10, 2026

A Method of Trigonometric Modelling of Seasonal Variation Demonstrated with Multiple Sclerosis Relapse Data
10:46

A Method of Trigonometric Modelling of Seasonal Variation Demonstrated with Multiple Sclerosis Relapse Data

Published on: December 9, 2015

Stochastic EM algorithm for doubly interval-censored data.

David Dejardin1, Emmanuel Lesaffre

  • 1Interuniversity Institute for Biostatistics and Statistical Bioinformatics, KULeuven and Universiteit Hasselt, Kapucijnenvoer 35, Blok D, Bus 7001, B3000 Leuven, Belgium.

Biostatistics (Oxford, England)
|June 4, 2013
PubMed
Summary
This summary is machine-generated.

This study addresses doubly interval-censored data in clinical trials, proposing a novel stochastic EM algorithm to accurately estimate treatment effects on event durations, overcoming limitations of existing survival analysis methods.

Keywords:
Cox proportional hazardDoubly interval censoredStochastic EM algorithm

More Related Videos

An R-Based Landscape Validation of a Competing Risk Model
05:37

An R-Based Landscape Validation of a Competing Risk Model

Published on: September 16, 2022

Related Experiment Videos

Last Updated: May 10, 2026

A Method of Trigonometric Modelling of Seasonal Variation Demonstrated with Multiple Sclerosis Relapse Data
10:46

A Method of Trigonometric Modelling of Seasonal Variation Demonstrated with Multiple Sclerosis Relapse Data

Published on: December 9, 2015

An R-Based Landscape Validation of a Competing Risk Model
05:37

An R-Based Landscape Validation of a Competing Risk Model

Published on: September 16, 2022

Area of Science:

  • Biostatistics
  • Clinical Trial Methodology
  • Survival Analysis

Background:

  • Estimating time between events (e.g., duration of response) is crucial in clinical trials.
  • Doubly interval-censored data arises when events occur between fixed assessment visits.
  • Existing survival techniques often oversimplify or inaccurately handle this data type.

Purpose of the Study:

  • To evaluate the impact of treatment on the duration of response endpoint using doubly interval-censored data.
  • To address the limitations of current survival analysis methods for this specific data structure.
  • To introduce a more accurate statistical approach for analyzing event durations in clinical trials.

Main Methods:

  • Review of existing survival analysis techniques and their limitations for doubly interval-censored data.
  • Development of a novel stochastic Expectation-Maximization (EM) algorithm.
  • Simulation studies to assess the finite sample properties of the proposed algorithm.

Main Results:

  • Existing methods demonstrate limitations when dealing with the nuances of doubly interval-censored data.
  • The proposed stochastic EM algorithm provides a viable solution for analyzing such data.
  • Simulation results indicate favorable finite sample properties of the new approach.

Conclusions:

  • The novel stochastic EM algorithm effectively handles doubly interval-censored data in clinical trials.
  • This method offers improved accuracy in estimating treatment effects on event durations.
  • The findings have significant implications for clinical trial design and data analysis in oncology and other fields.